Avience Biomedicals Ltd. has announced public offering of 1453800 shares at a price of Rs 10.00 each for Cash at a Premium of Rs 198.00 per share. The gross proceeds of the issue are expected to be Rs 3,023.90 lakhs.

The company's initial public offer (IPO) will open on 18 June 2026 and is expected to close on 22 June 2026, subject to customary closing conditions. The price band of the issue has been fixed at Rs 196.00-208.00 per share.

The IPO includes a fresh Issue of 1453800 Equity Shares of the Company at an price of Rs 208.00 per Equity Share. The company has fixed the minimum bid lot for the issue at 600 shares with bids in multiples of 600.

Avience Biomedicals Ltd. anticipates using the proceeds of the issue for .

Fintellectual Corporate Advisors Pvt. Ltd. as lead manager & Skyline Financial Services Pvt. Ltd. is the registrar, to the issue.